Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Basic Research in Cardiology
|
February 4, 2010
Kinases and phosphatases in ischaemic preconditioning: a re-evaluation
W J Fan, D van Vuuren, S Genade, et al.
Experimental Cell Research
|
March 23, 2011
At the core of survival: autophagy delays the onset of both apoptotic and necrotic cell death in a model of ischemic cell injury
B Loos, S Genade, B Ellis, et al.
Anesthesia and Analgesia
|
April 27, 2000
Reduction of postischemic contractile dysfunction of the isolated rat heart by sevoflurane: comparison with halothane
J F Coetzee, P J le Roux, S Genade, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
June 1, 1997
Ischaemic preconditioning does not protect hypertrophied myocardium against ischaemia
J A Moolman, S Genade, E Tromp, et al.
Anesthesia and Analgesia
|
August 1, 1994
Halothane protects the isolated rat myocardium against excessive total intracellular calcium and structural damage during ischemia and reperfusion
A Lochner, I S Harper, R Salie, et al.
Circulation
|
September 1, 1999
Ischemic preconditioning and the beta-adrenergic signal transduction pathway
A Lochner, S Genade, E Tromp, et al.
Journal of Molecular and Cellular Cardiology
|
December 12, 2001
p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning
E Marais, S Genade, H Strijdom, et al.
Life Sciences
|
April 14, 2009
Dexamethasone-induced cardioprotection: a role for the phosphatase MKP-1?
W-J Fan, S Genade, A Genis, et al.
Life Sciences
|
January 1, 1992
The role of alpha 1-adrenergic stimulation in inositol phosphate metabolism during post-ischaemic reperfusion
R Mouton, S Genade, S A Boschmans, et al.
Cardiovascular Drugs and Therapy
|
October 24, 2003
Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK
A Lochner, S Genade, S Hattingh, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Basic Research in Cardiology
|
February 4, 2010
Kinases and phosphatases in ischaemic preconditioning: a re-evaluation
W J Fan, D van Vuuren, S Genade, et al.
Experimental Cell Research
|
March 23, 2011
At the core of survival: autophagy delays the onset of both apoptotic and necrotic cell death in a model of ischemic cell injury
B Loos, S Genade, B Ellis, et al.
Anesthesia and Analgesia
|
April 27, 2000
Reduction of postischemic contractile dysfunction of the isolated rat heart by sevoflurane: comparison with halothane
J F Coetzee, P J le Roux, S Genade, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
June 1, 1997
Ischaemic preconditioning does not protect hypertrophied myocardium against ischaemia
J A Moolman, S Genade, E Tromp, et al.
Anesthesia and Analgesia
|
August 1, 1994
Halothane protects the isolated rat myocardium against excessive total intracellular calcium and structural damage during ischemia and reperfusion
A Lochner, I S Harper, R Salie, et al.
Circulation
|
September 1, 1999
Ischemic preconditioning and the beta-adrenergic signal transduction pathway
A Lochner, S Genade, E Tromp, et al.
Journal of Molecular and Cellular Cardiology
|
December 12, 2001
p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning
E Marais, S Genade, H Strijdom, et al.
Life Sciences
|
April 14, 2009
Dexamethasone-induced cardioprotection: a role for the phosphatase MKP-1?
W-J Fan, S Genade, A Genis, et al.
Life Sciences
|
January 1, 1992
The role of alpha 1-adrenergic stimulation in inositol phosphate metabolism during post-ischaemic reperfusion
R Mouton, S Genade, S A Boschmans, et al.
Cardiovascular Drugs and Therapy
|
October 24, 2003
Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK
A Lochner, S Genade, S Hattingh, et al.
Page
of 4